NASHVILLE, Tenn., April 30, 2020 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), a
global leader in life sciences solutions, today announced that the
Company will report financial results for the first quarter ended
March 31, 2020 on Thursday, May 7, 2020 after U.S. markets
close.
In addition to the earnings release, a document titled "Cryoport
First Quarter 2020 in Review", providing a review of Cryoport's
recent financial and operational performance and a general business
update, will be issued at 4:05 pm ET on
Thursday, May 7, 2020. The document is designed to be read
by investors before the questions and answers conference call and
can be accessed at
http://ir.cryoport.com/events-and-presentations.
Cryoport management will host a conference call at 5:00 pm ET on May 7,
2020. The conference call will be in the format of a
questions and answers session and will address any queries
investors have regarding the Company's reported results.
|
Conference Call
Information
|
|
Date:
|
May 7,
2020
|
|
Time:
|
5:00 p.m.
ET
|
|
Dial-in
numbers:
|
+1 (855) 327-6837
(U.S.), +1 (631) 891-4304 (International)
|
|
Confirmation
code:
|
Request the "Cryoport
Call"
|
|
Live
webcast:
|
'Investor Relations'
section at www.cryoport.com or at this link. Please allow 10
minutes prior to the call to visit this site to download and
install any necessary audio software.
|
Questions and answers will be recorded and available
approximately three hours after completion of the live event on the
Investor Relations section of the Company's website at
www.cryoport.com for a limited time. To access the replay of
the questions and answers, please follow this link. A dial-in
replay of the call will also be available, to those interested,
until May 14, 2020. To access the
replay, dial +1 (844) 512-2921 (United
States) or +1 (412) 317-6671 (International) and enter
replay pin number: 10009027.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is
redefining logistics for the life sciences industry by providing a
platform of temperature-controlled solutions, serving the
Biopharma, Reproductive Medicine, and Animal Health markets.
Our mission is to support life and health on earth by providing
reliable and comprehensive solutions for the life sciences industry
through our advanced technologies, Global Supply Chain Network and
dedicated scientists, technicians and supporting team of
professionals. Through purpose-built, proprietary Cryoport
Express® Shippers; Cryoportal® information
technology; validated operations; smart and sustainable
temperature-controlled logistics; and biostorage/biobanking
services, Cryoport serves clients in life sciences research,
clinical trials, and product commercialization. We support
life-saving advanced cell and gene therapies and deliver vaccines,
protein producing materials, and IVF materials in over 100
countries around the world. For more information, visit
www.cryoport.com or follow @cryoport on Twitter at
www.twitter.com/cryoport for live updates.
Forward Looking Statements
Statements in
this news release which are not purely historical, including
statements regarding Cryoport, Inc.'s intentions, hopes, beliefs,
expectations, representations, projections, plans or predictions of
the future are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. It is important
to note that the Company's actual results could differ materially
from those in any such forward-looking statements. Factors that
could cause actual results to differ materially include, but are
not limited to, risks and uncertainties associated with the effect
of changing economic conditions, trends in the products markets,
variations in the Company's cash flow, market acceptance risks, and
technical development risks. The Company's business could be
affected by a number of other factors, including the risk factors
listed from time to time in the Company's U.S. Securities and
Exchange Commission (SEC) reports including, but not limited to,
the Company's 10-K for the year ended December 31, 2019 filed with the SEC. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this press release.
Cryoport, Inc. disclaims any obligation, and does not undertake to
update or revise any forward-looking statements in this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-to-report-first-quarter-2020-financial-results-on-may-7-2020-301048005.html
SOURCE Cryoport, Inc.